Filtered By:
Specialty: Pharmaceuticals
Source: WSJ.com: Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 20 results found since Jan 2013.
Study Suggests Heart Patients May Need Fewer Blood Thinners
Researchers said a study involving reduced doses of Johnson& Johnson ’s anticoagulant Xarelto suggests it may be possible for patients with two types of heart disease to avoid the need for three different blood thinners to protect them from stroke and heart attack.
Source: WSJ.com: Health - November 15, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Merck Discontinues Development of Osteoporosis Drug
Merck said it would discontinue developing the osteoporosis drug odanacatib and not seek regulatory approval for the treatment because it carries a higher risk of stroke.
Source: WSJ.com: Health - September 2, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
High-Tech Tools Show Promise for Stroke Recovery
New devices, including some that use videogame and virtual-reality technology, can be more motivating and engaging for patients.
Source: WSJ.com: Health - June 27, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
AstraZeneca Says Its Blood Thinner No Better Than Aspirin in Stroke Trial
The drugmaker said Brilinta was no more effective than aspirin at preventing major heart problems in stroke patients, denting the company’s growth ambitions for one of its key drugs.
Source: WSJ.com: Health - March 23, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Low-Dose Aspirin Recommended at Ages 50 to 69
An influential federal panel recommended daily low-dose aspirin for men and women ages 50 to 69 to prevent heart attacks, stroke and colorectal cancer, setting off what is expected to be an intense debate given the drug’s side effects, including higher risk of bleeding.
Source: WSJ.com: Health - September 15, 2015 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA Strengthens Warnings on Class of Painkillers
The FDA strengthened its safety warnings about heart-attack and stroke risks linked to a class of common pain relievers that includes medicines such as Celebrex, Advil, Motrin IB and Aleve.
Source: WSJ.com: Health - July 10, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news
Stents Boost Stroke Recovery, Study Finds
A landmark study of stroke patients found that using devices known as stents to pull blood clots from brain arteries can significantly improve people’s ability to rebound from a stroke.
Source: WSJ.com: Health - December 18, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
More Study Urged on Testosterone Drugs
A Food and Drug Administration panel recommended that makers of testosterone-replacement drugs study possible increased risks of heart attack and stroke from the hot-selling products.
Source: WSJ.com: Health - September 18, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Finds Pradaxa Linked to Lower Stroke, Brain Hemorrhage Risk
A Food and Drug Administration analysis found the blood thinner Pradaxa was better at avoiding strokes and brain hemorrhage, though it was linked to more stomach bleeding.
Source: WSJ.com: Health - May 14, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Study on Stroke in Women Focuses on Risks From Pregnancy
Controlling blood pressure and risk factors related to pregnancy and use of birth control can significantly reduce a woman's chance of suffering a stroke later in life.
Source: WSJ.com: Health - February 7, 2014 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA Probes Risks of Testosterone-Boosting Drugs
The FDA said it is investigating the possible increased risk of stroke, heart attack and death in men who are taking testosterone-boosting products for the condition widely called "low-T."
Source: WSJ.com: Health - January 31, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Testosterone Therapy Tied to Heart Risks
Testosterone therapy raised the risk of death, heart attack and stroke by about 30% in a group of veterans with a history of heart disease, according to a new study.
Source: WSJ.com: Health - November 6, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
Common Stroke Screening Is Under Review
Health panel takes a new look at carotid-artery ultrasounds, which can produce false positive results and may lead to treatments that do more harm than good.
Source: WSJ.com: Health - September 8, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news
